DHEA treatment of Alzheimer's disease: A randomize... [Neurology. 2004] - PubMed

loading

DHEA for Alzheimer's disease: a modest showing by a superhormone. [Neurology. 2003]
DHEA for Alzheimer's disease: a modest showing by a superhormone.
Knopman D, Henderson VW. Neurology. 2003 Apr 8; 60(7):1060-1.
Antiglucocorticoid effects of DHEA-S in Alzheimer's disease. [Am J Psychiatry. 1992]
Antiglucocorticoid effects of DHEA-S in Alzheimer's disease.
Leblhuber F, Windhager E, Neubauer C, Weber J, Reisecker F, Dienstl E. Am J Psychiatry. 1992 Aug; 149(8):1125-6.
Role of DHEA and DHEA-S in Alzheimer's disease. [Am J Psychiatry. 1993]
Role of DHEA and DHEA-S in Alzheimer's disease.
Adinoff B, Martin PR, Eckardt MJ, Linnoila M. Am J Psychiatry. 1993 Sep; 150(9):1432-3.
Review Cholinesterase inhibitors for Alzheimer's disease. [Cochrane Database Syst Rev. 2006]
Review Cholinesterase inhibitors for Alzheimer's disease.
Birks J. Cochrane Database Syst Rev. 2006 Jan 25; (1):CD005593. Epub 2006 Jan 25.
Review WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function. [Cochrane Database Syst Rev. 2007]
Review WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Huppert FA, Van Niekerk JK. Cochrane Database Syst Rev. 2007 Jul 18; (2):CD000304. Epub 2007 Jul 18.

Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates. [Age (Dordr). 2007]
Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.
Braverman ER, Chen TJ, Prihoda TJ, Sonntag W, Meshkin B, Downs BW, Mengucci JF, Blum SH, Notaro A, Arcuri V, et al. Age (Dordr). 2007 Sep; 29(2-3):55-67. Epub 2007 May 12.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-contr...
DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial.
Neurology. 2004 Mar 23 ;62(6):1030.

PubMed
POMT1 mutation results in defective glycosylation and loss of laminin-binding ac...
POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG.
Neurology. 2004 Mar 23 ;62(6):1009-11.

PubMed
Ethical consideration of incidental findings on adult brain MRI in research.
Ethical consideration of incidental findings on adult brain MRI in research.
Neurology. 2004 Mar 23 ;62(6):888-90.

PubMed
Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates ...
Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation.
J Biol Chem. 2004 Jun 4 ;279(23):24343-54. Epub 2004 Mar 22 .

PubMed
Magic angle effects in MR neurography.
Magic angle effects in MR neurography.
AJNR Am J Neuroradiol. 2004 Mar ;25(3):431-40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed